基于遗传因果关系的新药针对痴呆症的新药目标
Shouqiang Zhu1, Xiahao Ding1, Jinhua Bo2
1Department of Anesthesiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China; Medical School, Nanjing University, Nanjing, Jiangsu Province, China; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, Jiangsu Province, China.
这项研究使用了门德尔随机化来找到五种可用药物的基因标,用于治疗妄想症. 这些发现可能会加速药物开发,并降低有效的妄想疗法的成本.
科学领域:
- 遗传学和基因组学 在
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 痴呆症的治疗和预防受到识别和验证药物点的挑战的阻碍.
- 进行了一项系统的门德尔随机化 (MR) 研究,通过探索可用药物的基因组以寻找潜在的妄想治疗标来弥补这一差距.
研究的目的:
- 确定和验证可药物治疗的基因标,以有效治疗和预防妄想.
- 利用先进的基因分析来发现神妄的新型治疗策略.
主要方法:
- 使用来自血液和大脑样本的cis-eQTL数据,进行了门德尔随机化 (MR) 和局部化分析.
- 利用全基因组关联研究 (GWAS) 的痴呆症数据,包括大型发现和验证队列.
- 进一步的分析包括PheWAS,丰富分析,蛋白质网络构造,药物预测,分子对接和调解分析.
主要成果:
- 鉴定出了五个重要的可药物治疗的妄基因标:C4BPA,A2M,GRIK4,C1R (来自血液) 和SUMF1 (来自血液和大脑).
- 这些已识别的基因与免疫功能具有强烈的生物学关联.
- 调解分析表明,C4BPA占与衰老相关的狂妄症风险的16.7%,分子对接显示出有希望的药物蛋白结合.
结论:
- 在MR分析成功地确定了五个潜在的可用药物的妄治疗目标.
- 预计这些基因的向将增加痴呆症治疗临床试验的成功率.
- 这项研究旨在优先考虑妄症治疗的开发,并降低相关的药物开发成本.
更多相关视频
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:22A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
Published on: June 22, 2015
相关概念视频
Alzheimer's Disease: Treatment
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
